These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 32850364)
1. Deregulation of Polycomb Repressive Complex-2 in Mantle Cell Lymphoma Confers Growth Advantage by Epigenetic Suppression of Demosthenous C; Gupta SK; Sun J; Wang Y; Troska TP; Gupta M Front Oncol; 2020; 10():1226. PubMed ID: 32850364 [TBL] [Abstract][Full Text] [Related]
2. EZH2 expression is associated with inferior overall survival in mantle cell lymphoma. Martinez-Baquero D; Sakhdari A; Mo H; Kim DH; Kanagal-Shamanna R; Li S; Young KH; O'Malley DP; Dogan A; Jain P; Wang ML; McDonnell TJ; Miranda RN; Vega F; Medeiros LJ; Ok CY Mod Pathol; 2021 Dec; 34(12):2183-2191. PubMed ID: 34376807 [TBL] [Abstract][Full Text] [Related]
4. EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia. Schäfer V; Ernst J; Rinke J; Winkelmann N; Beck JF; Hochhaus A; Gruhn B; Ernst T J Cancer Res Clin Oncol; 2016 Jul; 142(7):1641-50. PubMed ID: 27169594 [TBL] [Abstract][Full Text] [Related]
5. The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma. Visser HP; Gunster MJ; Kluin-Nelemans HC; Manders EM; Raaphorst FM; Meijer CJ; Willemze R; Otte AP Br J Haematol; 2001 Mar; 112(4):950-8. PubMed ID: 11298590 [TBL] [Abstract][Full Text] [Related]
6. Astemizole arrests the proliferation of cancer cells by disrupting the EZH2-EED interaction of polycomb repressive complex 2. Kong X; Chen L; Jiao L; Jiang X; Lian F; Lu J; Zhu K; Du D; Liu J; Ding H; Zhang N; Shen J; Zheng M; Chen K; Liu X; Jiang H; Luo C J Med Chem; 2014 Nov; 57(22):9512-21. PubMed ID: 25369470 [TBL] [Abstract][Full Text] [Related]
7. Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer. Chen H; Gao S; Li J; Liu D; Sheng C; Yao C; Jiang W; Wu J; Chen S; Huang W Oncotarget; 2015 May; 6(15):13049-59. PubMed ID: 25944687 [TBL] [Abstract][Full Text] [Related]
8. Degradation of Polycomb Repressive Complex 2 with an EED-Targeted Bivalent Chemical Degrader. Potjewyd F; Turner AW; Beri J; Rectenwald JM; Norris-Drouin JL; Cholensky SH; Margolis DM; Pearce KH; Herring LE; James LI Cell Chem Biol; 2020 Jan; 27(1):47-56.e15. PubMed ID: 31831267 [TBL] [Abstract][Full Text] [Related]
9. Long Non-coding RNA HOTAIR Expression in Diffuse Large B-Cell Lymphoma: In Relation to Polycomb Repressive Complex Pathway Proteins and H3K27 Trimethylation. Oh EJ; Kim SH; Yang WI; Ko YH; Yoon SO J Pathol Transl Med; 2016 Sep; 50(5):369-76. PubMed ID: 27550047 [TBL] [Abstract][Full Text] [Related]
10. Structure of the catalytic domain of EZH2 reveals conformational plasticity in cofactor and substrate binding sites and explains oncogenic mutations. Wu H; Zeng H; Dong A; Li F; He H; Senisterra G; Seitova A; Duan S; Brown PJ; Vedadi M; Arrowsmith CH; Schapira M PLoS One; 2013; 8(12):e83737. PubMed ID: 24367611 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic vulnerabilities of leukemia harboring inactivating EZH2 mutations. Alqazzaz MA; Luciani GM; Vu V; Machado RAC; Szewczyk MM; Adamson EC; Cheon S; Li F; Arrowsmith CH; Minden MD; Barsyte-Lovejoy D Exp Hematol; 2024 Feb; 130():104135. PubMed ID: 38072134 [TBL] [Abstract][Full Text] [Related]
12. The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications. Kim SH; Yang WI; Min YH; Ko YH; Yoon SO Tumour Biol; 2016 Feb; 37(2):2037-47. PubMed ID: 26337274 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA profile in mantle cell lymphoma identifies a functional lncRNA ROR1-AS1 associated with EZH2/PRC2 complex. Hu G; Gupta SK; Troska TP; Nair A; Gupta M Oncotarget; 2017 Oct; 8(46):80223-80234. PubMed ID: 29113297 [TBL] [Abstract][Full Text] [Related]
14. Identification and Assessments of Novel and Potent Small-Molecule Inhibitors of EED-EZH2 Interaction of Polycomb Repressive Complex 2 by Computational Methods and Biological Evaluations. Zhu K; Du D; Yang R; Tao H; Zhang H Chem Pharm Bull (Tokyo); 2020 Jan; 68(1):58-63. PubMed ID: 31685780 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential. Gan L; Yang Y; Li Q; Feng Y; Liu T; Guo W Biomark Res; 2018; 6():10. PubMed ID: 29556394 [TBL] [Abstract][Full Text] [Related]
16. Regulation of T Cell Differentiation and Function by EZH2. Karantanos T; Chistofides A; Barhdan K; Li L; Boussiotis VA Front Immunol; 2016; 7():172. PubMed ID: 27199994 [TBL] [Abstract][Full Text] [Related]
17. EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 Complex. Hsu JH; Rasmusson T; Robinson J; Pachl F; Read J; Kawatkar S; O' Donovan DH; Bagal S; Code E; Rawlins P; Argyrou A; Tomlinson R; Gao N; Zhu X; Chiarparin E; Jacques K; Shen M; Woods H; Bednarski E; Wilson DM; Drew L; Castaldi MP; Fawell S; Bloecher A Cell Chem Biol; 2020 Jan; 27(1):41-46.e17. PubMed ID: 31786184 [TBL] [Abstract][Full Text] [Related]
18. EZH2-Mediated H3K27me3 Targets Transcriptional Circuits of Neuronal Differentiation. Buontempo S; Laise P; Hughes JM; Trattaro S; Das V; Rencurel C; Testa G Front Neurosci; 2022; 16():814144. PubMed ID: 35645710 [TBL] [Abstract][Full Text] [Related]
19. Aberrations of EZH2 in cancer. Chase A; Cross NC Clin Cancer Res; 2011 May; 17(9):2613-8. PubMed ID: 21367748 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of Polycomb Repressive Complex 2 activity reduces trimethylation of H3K27 and affects development in Arabidopsis seedlings. Ruta V; Longo C; Boccaccini A; Madia VN; Saccoliti F; Tudino V; Di Santo R; Lorrai R; Dello Ioio R; Sabatini S; Costi R; Costantino P; Vittorioso P BMC Plant Biol; 2019 Oct; 19(1):429. PubMed ID: 31619182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]